JOSÉ A. CABRANES, Circuit Judge:
This appeal primarily concerns the requirements for proving an adverse effect on competition for purposes of section 1 of the Sherman Act, 15 U.S.C. § 1, in cases where the plaintiff has not proved that the allegedly anticompetitive behavior led to higher prices, reduced output, or lower quality in the market. We hold that in such cases, a plaintiff may not prevail under the "rule of reason" merely by proving that (1) the defendant exercised "market power," and (2) the challenged behavior may have misled consumers to believe that certain products were no longer available, without showing that consumers actually experienced reduced access to those products.
Defendant-appellant Cortron Corp. ("Cortron") appeals from a February 17, 2015 judgment of the United States District Court for the District of Connecticut (Michael P. Shea, Judge), which awarded damages of $64,670,821 pursuant to a jury verdict for plaintiff-appellee MacDermid Printing Solutions LLC ("MacDermid") on its claims for violations of federal and Connecticut antitrust laws, breach of contract, misappropriation of trade secrets, spoliation, and violations of Connecticut statutes prohibiting computer crimes and unfair trade practices. MacDermid had alleged that its commercial rival, nonparty E.I. du Pont de Nemours & Co. ("DuPont"), filed a bogus patent-infringement suit against Cortron, MacDermid's supplier, and that when Cortron and DuPont settled that suit, they entered into an anticompetitive conspiracy that damaged MacDermid's business and hurt consumers.
On appeal, Cortron argues that the District Court erred in (1) denying Cortron a new trial or judgment as a matter of law on its antitrust claims; (2) permitting MacDermid to present evidence of its lawyers' patent advice; (3) concluding that the jury's identical awards on each of the antitrust claims were not duplicative; and (4) failing to remit or to order a new trial on damages regarding the antitrust and trade-secrets claims.
MacDermid and DuPont market thermal flexographic processors, which are used to make plates for printing commercial packaging. Such processors are typically sold either to commercial printers, which produce packaging for consumer-goods companies, or to "trade shops," which supply plates to commercial printers.
DuPont introduced the first thermal flexographic processor in 2000, under the "FAST" trade name. In 2002, MacDermid began to develop an alternative to FAST, which it introduced in 2004 under the "LAVA" trade name. At all relevant times, MacDermid and DuPont were the only companies that marketed thermal flexographic processors, and DuPont had a dominant share of that market.
Soon after introducing its LAVA machines, MacDermid entered into two contracts with Cortron. Under the "Joint Development Agreement," signed in November 2004, MacDermid would pay Cortron to develop a second-generation LAVA processor. Under the "Manufacturing Agreement," signed in April 2005, MacDermid would pay Cortron to build first-generation LAVA processors and to safeguard MacDermid's proprietary information.
In 2008, DuPont scheduled a meeting with Cortron, ostensibly to discuss potential business opportunities. During the meeting, which took place on April 1, 2008, DuPont informed Cortron that it had filed a lawsuit alleging that Cortron's work for MacDermid infringed DuPont Patent No. 6,797,454 ("the '454 patent").
DuPont and Cortron settled that suit in June 2008. As part of the settlement, Cortron agreed "to immediately cease manufacturing, selling, and offering to sell" thermal flexographic systems;
DuPont announced the settlement in a press release issued on July 30, 2008:
Unsurprisingly, DuPont hoped that this press release would make potential customers "more likely to buy DuPont's FAST" processors and "less likely" to buy MacDermid's competing LAVA products.
Meanwhile, MacDermid had already started searching for a new manufacturer to replace Cortron. MacDermid had been concerned about Cortron's financial stability even before the DuPont lawsuit. In 2007, MacDermid had started to plan for Cortron's potential failure, and by February 2008, MacDermid had contacted three possible alternative suppliers. MacDermid's concerns only deepened after it learned about the pending litigation. In July 2008 — after learning about DuPont's lawsuit, but before the Cortron-DuPont settlement agreement was announced — MacDermid decided to switch from Cortron to a new manufacturer, OLEC Corporation.
Ordinarily, MacDermid would have expected Cortron to facilitate the transition by transferring to OLEC any technical information it had regarding LAVA machines. But because Cortron had given all extant LAVA technical information to DuPont, and because MacDermid did not have its own copy of that information, OLEC had to reverse-engineer the specifications needed to manufacture new LAVA machines. The reverse-engineering process cost $29,970 and took about nine months. During this transition period, MacDermid was unable to obtain new LAVA machines. Nonetheless, MacDermid always retained an inventory of LAVA processors and "never was unable to fulfill a sale," according to the testimony of its general manager.
MacDermid filed the instant action in September 2008 in Connecticut state court, alleging that Cortron and DuPont had engaged in an antitrust conspiracy in violation of section 1 of the Sherman Act, 15 U.S.C. § 1, and the Connecticut Antitrust Act, Conn. Gen. Stat. §§ 35-26, 35-28. MacDermid also brought claims under the Connecticut Uniform Trade Secrets Act ("CUTSA"), Conn. Gen. Stat. §§ 35-50 to 35-58; under the state computer-crime statute, Conn. Gen. Stat. §§ 53a-251, 52-570b;
After a trial in June and July 2014, the jury found for MacDermid on all issues and awarded it approximately $35.4 million in compensatory damages.
We first consider Cortron's argument that the District Court erred in denying it judgment as a matter of law ("JMOL") on MacDermid's federal and state antitrust claims.
We review de novo a district court's denial of JMOL pursuant to Rule 50(b) of the Federal Rules of Civil Procedure.
"In order for a party to pursue a request for JMOL on appeal, the party must have made timely motions for JMOL in the district court."
Here, Cortron moved for JMOL both before and after the case was submitted to the jury. The parties disagree, however, about which arguments Cortron preserved in its Rule 50(a) motion. The District Court found that Cortron properly preserved its argument that MacDermid had failed to prove harm to competition, but that it did not preserve several other arguments raised in its Rule 50(b) motion.
We agree with the District Court that Cortron preserved its argument that MacDermid failed to prove harm to competition
MacDermid's federal and state antitrust claims are identical for purposes of this appeal.
Section 1 of the Sherman Act prohibits, in relevant part, "[e]very contract, combination in the form of trust or otherwise, or conspiracy, in restraint of trade or commerce."
A plaintiff seeking to prove an antitrust violation under the rule of reason must initially show that the challenged action adversely affected competition in the relevant market.
In Tops Markets, Inc. v. Quality Markets, Inc., we held that a plaintiff seeking to prove an adverse effect indirectly need show only "that the challenged behavior could harm competition."
Indeed, although we have sometimes described "direct" and "indirect" proof as alternative ways of satisfying the adverse-effect requirement, there is really only one way to prove an adverse effect on competition under the rule of reason: by showing actual harm to consumers in the relevant market.
Our cases suggest that it is possible, at least in theory, to prove that a challenged action harmed competition without offering evidence of higher prices, reduced output, or reduced quality. We have never explained, however, what such proof would look like. Indeed, in no precedential opinion in this Circuit has a plaintiff successfully proved an adverse effect on competition without offering evidence of changed prices, output, or quality.
We first discussed "indirect" proof in Capital Imaging Associates, P.C. v. Mohawk Valley Medical Associates, Inc.
We revisited the issue in K.M.B. Warehouse Distributors, Inc. v. Walker Manufacturing Co.
We did suggest, in dicta, two possible examples of such "other grounds": "the inherent[ly] anticompetitive nature of [a] defendant's behavior or the structure of the interbrand market."
In sum, proving an adverse effect on competition without showing increased price, reduced output, or reduced quality in the market has remained possible in theory but elusive in practice.
MacDermid sought to prove an antitrust violation under the rule of reason. As such, it was required to prove an adverse effect on competition. It has failed to do so here.
As an initial matter, we agree with the District Court that MacDermid has not directly proved an adverse effect on competition.
Nor has MacDermid produced evidence that the purported conspiracy led to reduced output in the market. A reasonable jury could have found that the Cortron-DuPont settlement resulted in MacDermid's losing its critical supplier, which in turn prevented the production of new LAVA machines for about nine months. But while this disruption may have reduced the total number of thermal flexographic processors in the world, it did not reduce the number of such processors from the perspective of consumers.
We note, finally, that MacDermid does not argue that the purported conspiracy reduced the overall quality of processors in the market.
As discussed above, to prove harm to competition indirectly, MacDermid was required to show (1) that the conspirators had sufficient "market power" to cause an adverse effect, and (2) "some other ground for believing that the challenged behavior" harmed competition.
MacDermid offers three possible reasons to believe that Cortron's behavior harmed competition, none of which has merit. First, MacDermid suggests that the Cortron-DuPont settlement "was inherently anticompetitive" because "Cortron and DuPont had a competitive relationship at the time."
Second, MacDermid argues that "the relevant interbrand market was a duopoly," which "is ground alone for finding [that] the challenged behavior harmed competition."
Finally, MacDermid argues that the Cortron-DuPont conspiracy harmed competition by reducing the range of options available to consumers. MacDermid is correct that reduced consumer choice can constitute harm to competition.
MacDermid argues, and the District Court found, that the Cortron-DuPont conspiracy — and especially DuPont's press release — could have led "consumers to believe that MacDermid's LAVA technology was no longer available."
The record shows that customers continued to buy LAVA machines even after July 2008, when DuPont announced its settlement with Cortron and when MacDermid switched suppliers.
It is certainly possible that the purported Cortron-DuPont conspiracy, including DuPont's press release, led some consumers to buy DuPont machines instead of MacDermid ones. But even if true, that would merely establish harm to MacDermid, not harm to competition in the market as a whole. "[B]ecause the antitrust laws protect competition, not competitors," a plaintiff must show that more than its own business suffered; it must ultimately show that the challenged action harmed consumers.
We next consider Cortron's argument that the District Court "abused its discretion" in permitting MacDermid to present evidence of its patent counsel's advice, which it had previously withheld based on claims of attorney-client privilege and the work-product doctrine.
The events leading to this appeal began with a patent-infringement suit filed by DuPont, alleging that Cortron's work for MacDermid had infringed DuPont's '454 patent. Whether Cortron or MacDermid has, in fact, infringed any DuPont patent is not directly at issue in this litigation.
Accordingly, during discovery in 2009, Cortron sought evidence, through document requests, interrogatories, and depositions, about MacDermid's efforts to determine whether its LAVA machines infringed any DuPont patent. MacDermid initially resisted some of these discovery requests by invoking the attorney-client privilege and the work-product doctrine.
In September 2012, however, the United States District Court for the District of New Jersey held, in related litigation between DuPont and MacDermid, that MacDermid had waived any privileges regarding the advice of its patent counsel about the design of LAVA machines and their potential infringement of DuPont patents. In response to that ruling, MacDermid supplemented its production of documents in the instant litigation and amended its exhibit and witness lists. Included among MacDermid's new proposed exhibits was an opinion by the law firm of Wiggin & Dana LLP stating that LAVA processors did not infringe DuPont's '454 patent.
On September 6, 2013, Cortron filed a motion in limine to preclude MacDermid from presenting the newly disclosed evidence. The District Court granted the motion in part and denied it in part in an order of June 4, 2014.
To avoid prejudicing Cortron, the District Court permitted Cortron to engage in additional discovery in response to MacDermid's newly disclosed evidence.
Pursuant to the District Court's order, MacDermid supplemented its interrogatory response, and Cortron re-deposed four witnesses between June 6 and June 13, 2014. MacDermid also provided Cortron with a transcript of an earlier deposition of Cordani in New Jersey. Cortron declined to designate an expert on the subject of infringement.
A party challenging a district court's evidentiary ruling is generally entitled to a new trial if (1) "the district court committed errors that were a clear abuse of discretion," and (2) those errors "were clearly prejudicial to the outcome of the trial, where prejudice is measured by assessing the error in light of the record as a whole."
Cortron has not met this burden. First, Cortron has not even shown that the District Court erred, much less "abused its discretion," in admitting the challenged evidence. We have generally been reluctant to second-guess a district court's decision whether to exclude evidence previously withheld as privileged.
A district court "may be fully entitled" to preclude the presentation of evidence
Nor has Cortron shown that it was prejudiced by the District Court's ruling. Cortron had ample opportunity to respond to MacDermid's late disclosures and to prepare to rebut the newly produced evidence at trial. MacDermid invited Cortron in September 2013 — eight months before the evidentiary ruling at issue here — to depose Cordani on the questions as to which MacDermid had previously asserted a privilege. Cortron declined to do so. After the District Court's ruling of June 4, 2014, Cortron re-deposed Cordani and three other witnesses, and MacDermid supplemented its relevant interrogatory response. The District Court also offered Cortron an opportunity to designate an expert on patent validity, but Cortron declined to do that as well. Moreover, Cortron rejected an opportunity to pursue a continuance.
Finally, we consider Cortron's argument that the jury's award of $3,790,939 for damages under CUTSA was excessive, and that the District Court therefore should have remitted the award or ordered a new trial on CUTSA damages.
We review for "abuse of discretion" a district court's denial of remittitur or a new trial on damages.
Under Connecticut law, "the relevant inquiry" in determining whether an award is excessive is whether it "falls within the necessarily uncertain limits of fair and reasonable compensation or whether it so shocks the conscience as to compel the conclusion that it was due to partiality, prejudice or mistake."
Cortron argues that the jury's award of damages under CUTSA lacked an evidentiary basis. MacDermid's CUTSA claim derived from Cortron's transfer to DuPont of technical information for LAVA machines. The jury's award of damages was based on an estimate by MacDermid's expert, James Levinsohn, of the amount Cortron and MacDermid would have agreed Cortron would pay in a "hypothetical negotiation" for the right to give DuPont that information.
Cortron does not challenge Levinsohn's use of a hypothetical negotiation to estimate CUTSA damages.
Under Connecticut law, a jury is entitled to award damages that are based on an expert's estimate, especially when that estimate is based on calculations that have been explained to the jury.
We therefore conclude that the District Court did not err, much less "abuse its discretion," in allowing the jury's award to stand.
To summarize, we hold as follows:
For the foregoing reasons, we
The question of infringement was also potentially relevant to MacDermid's antitrust claims. Cortron essentially argued that if DuPont had an objective basis for thinking that LAVA infringed the '454 patent, then DuPont's patent-infringement suit against Cortron was not an anticompetitive sham that violated federal and state antitrust laws. See Prof'l Real Estate Inv'rs, Inc. v. Columbia Pictures Indus., Inc., 508 U.S. 49, 51, 61, 113 S.Ct. 1920, 123 L.Ed.2d 611 (1993) (holding that patent litigation is generally immune from antitrust liability as long as it is not (1) "objectively baseless" and (2) subjectively intended "as an anticompetitive weapon" (internal quotation marks omitted)). Because we hold that MacDermid's antitrust claim fails as a matter of law on other grounds, we need not consider whether DuPont's suit was objectively baseless. See also ante (discussing whether Cortron waived this argument).